Daiichi Life Insurance Co. Ltd. Makes New $735,000 Investment in IDEX Corporation $IEX

Daiichi Life Insurance Co. Ltd. acquired a new position in IDEX Corporation (NYSE:IEXFree Report) in the second quarter, HoldingsChannel reports. The institutional investor acquired 3,239 shares of the industrial products company’s stock, valued at approximately $735,000.

Several other institutional investors and hedge funds have also recently modified their holdings of IEX. Empowered Funds LLC lifted its stake in shares of IDEX by 3.4% during the 1st quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock valued at $298,000 after buying an additional 54 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in IDEX by 41.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,043 shares of the industrial products company’s stock worth $183,000 after buying an additional 304 shares in the last quarter. Cresset Asset Management LLC purchased a new stake in IDEX in the 2nd quarter worth $219,000. Cerity Partners LLC raised its holdings in IDEX by 23.9% during the second quarter. Cerity Partners LLC now owns 18,658 shares of the industrial products company’s stock valued at $3,276,000 after acquiring an additional 3,604 shares during the period. Finally, Daiwa Securities Group Inc. raised its holdings in IDEX by 4.0% during the second quarter. Daiwa Securities Group Inc. now owns 13,513 shares of the industrial products company’s stock valued at $2,373,000 after acquiring an additional 518 shares during the period. 97.96% of the stock is currently owned by institutional investors.

IDEX Stock Performance

NYSE:IEX opened at $233.51 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15. IDEX Corporation has a 1 year low of $158.19 and a 1 year high of $243.80. The stock’s 50 day simple moving average is $228.11 and its two-hundred day simple moving average is $213.20. The company has a market cap of $17.21 billion, a price-to-earnings ratio of 33.60, a PEG ratio of 2.21 and a beta of 0.98.

IDEX (NYSE:IEXGet Free Report) last posted its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The firm had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period in the prior year, the company earned $2.07 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. As a group, equities analysts anticipate that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.

IDEX Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were paid a dividend of $0.73 per share. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a yield of 1.3%. IDEX’s dividend payout ratio is presently 42.01%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on IEX. Royal Bank Of Canada upped their price objective on IDEX from $261.00 to $280.00 and gave the stock an “outperform” rating in a research note on Thursday, July 30th. Stifel Nicolaus lifted their target price on IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Mizuho raised IDEX from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $210.00 to $280.00 in a report on Tuesday, August 11th. Seaport Research Partners restated a “buy” rating and issued a $250.00 price target on shares of IDEX in a research note on Tuesday, May 5th. Finally, Robert W. Baird set a $257.00 price target on IDEX in a research note on Thursday, April 30th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $260.80.

Read Our Latest Analysis on IDEX

Insider Buying and Selling

In other IDEX news, CAO Lisa M. Anderson sold 385 shares of the stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total transaction of $91,857.15. Following the completion of the transaction, the chief accounting officer owned 4,327 shares in the company, valued at $1,032,378.93. This trade represents a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.50% of the stock is owned by company insiders.

About IDEX

(Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Read More

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEXFree Report).

Institutional Ownership by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.